Status:
COMPLETED
CORE: CO Monitoring for Reach and Efficacy in Tobacco Treatment for Cancer Patients
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Conditions:
Tobacco Use
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess the cessation success rates of an intensive tobacco treatment program in a patients undergoing cancer treatment at 30 days, 3 months and 6 months.
Detailed Description
This mixed-methods, observational cohort study will assess intensive tobacco treatment with carbon monoxide monitoring offered to all eligible smoking patients presenting for cancer treatment to the N...
Eligibility Criteria
Inclusion
- Adults age 18 and older
- Active Smoker at the time of initial consultation for cancer (defined as any smoking within 2 weeks of consult)
Exclusion
- Adults unable to consent
- Prisoners
Key Trial Info
Start Date :
January 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 16 2024
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT04675515
Start Date
January 19 2021
End Date
February 16 2024
Last Update
July 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756